Who is sponsoring NCT05173740?

NCT05173740 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT05173740?

Interventions in NCT05173740: Individually tailored rehabilitation intervention, Usual care.

What condition does NCT05173740 study?

NCT05173740 studies Cardiac Arrest, Heart Arrest, Cardiopulmonary Resuscitation, Return to Work, Return-to-work, Rehabilitation, Recovery of Function, Cardiac Rehabilitation.

Is NCT05173740 still recruiting?

NCT05173740 is currently recruiting now. Last updated 8 December 2025.

Last reviewed 2025-12-08 · How we verify

NCT05173740

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rehabilitation for Survivors of Out-of-hospital Cardiac Arrest

Recruiting now Phase 4 Last updated 8 December 2025

What this trial tests

Phase 4 trial testing Individually tailored rehabilitation intervention in Cardiac Arrest in 214 participants. Currently enrolling.

Timeline

1 February 2022

Primary endpoint
31 July 2027

31 July 2028

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	Phase 4
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	214
Start date	1 February 2022
Primary completion	31 July 2027
Estimated completion	31 July 2028
Sites	1 location across Denmark

Drugs / interventions tested

Individually tailored rehabilitation intervention
Usual care

Conditions studied

Cardiac Arrest — all drugs for Cardiac Arrest →
Heart Arrest — all drugs for Heart Arrest →
Cardiopulmonary Resuscitation — all drugs for Cardiopulmonary Resuscitation →
Return to Work — all drugs for Return to Work →

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 18 to 65, any sex, with Cardiac Arrest or Heart Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a parallel group multicentre investigator-initiated clinical randomised controlled superiority trial that will include a total of 214 survivors of OHCA. Participants will to be randomized with a 1:1 allocation ratio to either a intervention consisting of a comprehensive initiated tailored rehabilitation intervention focusing on supporting RTW plus usual care compared to usual care alone.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A multidisciplinary guideline-based approach to improving the sudden cardiac arrest care pathway: The Copenhagen framework.
Wagner MK, Christensen J, Christensen KA, Dichman C, et al · · 2024 · cited 10× · PMID 38260118 · DOI 10.1016/j.resplu.2023.100546
The ROCK trial-a multidisciplinary Rehabilitation intervention for sudden Out-of-hospital Cardiac arrest survivors focusing on return-to-worK: a pragmatic randomized controlled trial protocol.
Christensen J, Winkel BG, Kirkeskov L, Folke F, et al · · 2024 · cited 5× · PMID 38303019 · DOI 10.1186/s13063-024-07911-6

Verify or expand the search:

Other recruiting trials for Cardiac Arrest

Currently open trials in the same condition.

NCT07239206 — Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses · NA · recruiting
NCT06780722 — Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Proced · recruiting
NCT06405581 — The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation · recruiting
NCT06511999 — Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest · recruiting
NCT07113769 — Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05173740 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 8 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05173740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing